NANO-PSO therapy for improving cognition in older adults with cognitive impairment
Official title: Impact of NANO-PSO (omega 5) Supplementation on Cognitive Abilities of Older Adults with Mild to Moderate Non-vascular Cognitive Impairment
Run by Distribuidora Biolife SA de CV · NCT06520878 · Data updated 2026-11-12
This study is testing if a pomegranate seed oil supplement can help older adults with mild to moderate cognitive impairment think better over six months.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 60 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Distribuidora Biolife SA de CV Industry-sponsored |
| Locations | 1 site (Miguel Hidalgo, Mexico City) |
| Status | Recruiting |
| Started | February 12, 2025 |
| Main results expected | December 1, 2025 |
| Study ends | December 1, 2025 |
| Registry record updated | February 6, 2025 |
| Trial ID | NCT06520878 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are older adults aged 60 and above with mild to moderate cognitive impairment who meet specific diagnostic criteria for probable dementia.
✕Probably not a fit
Patients with severe cognitive impairment or those not meeting the inclusion criteria for dementia may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the effectiveness of NANO-PSO, a pomegranate seed oil supplement, in enhancing cognitive abilities among older adults aged 60 and above who have mild to moderate non-vascular cognitive impairment. Participants will be randomly assigned to receive either NANO-PSO or a placebo for six months, with monthly phone evaluations and in-person assessments at 90 and 180 days to monitor progress and adherence. The study aims to determine if NANO-PSO can significantly improve cognitive function compared to a placebo.
Why it matters
Potential benefit: If successful, this therapy could provide a new, non-invasive option for improving cognitive function in older adults with cognitive impairment.
How similar studies have gone: While there have been studies on cognitive enhancement supplements, the specific use of NANO-PSO in this context is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients attended at the Hospital Español. * Patients of any gender who are 60 years or older. * Patients presenting with mild to moderate cognitive impairment. * Meet the diagnostic criteria for \"probable dementia\" of the National Institute on Aging and the Alzheimer's Association (NIA-AA) (2011). * Meet the criteria for the typical variant of Alzheimer's disease, specifically a specific clinical phenotype. * Progressive and gradual change in memory functions reported by the patient or the informant for at least 6 months. * Objective evidence of a hippocampal-type amnesic syndrome, based on significant impairment in the performance of episodic memory tests with established specificity for AD. * Subjects are primary and secondary school graduates and have the ability to complete cognitive capacity tests and other specified tests in the program. * Total score on the Hachinski Ischemic Scale (HIS) ≤ 4. * Patients who sign the informed consent. Exclusion Criteria: * Patients with known allergy to any component of the NANO-PSO capsule (e.g., fish). * Patients with short bowel syndrome, bariatric surgery, or gluten reaction that may affect intestinal absorption. * Patients in palliative care with a life expectancy of less than 6 months according to the NECPAL scale. * Patients with terminality criteria established in the comprehensive palliative care management guide of Mexico.
Where it's running
-
Hospital Español. Av Ejercito Nacional 613, Miguel Hidalgo, CDMX, 11520
Miguel Hidalgo, Mexico City, Mexico Recruiting
Study contacts
- Principal investigator: Alejandro Padilla Isassi, Geriatrician and researcher — Distribuidora Biolife S.A. de C.V.
- Study coordinator: Alejandro Padilla Isassi, Geriatrician and researcher
- Email: alejandropadillaisassi@gmail.com
- Phone: +525589510727
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Can the Ronnie Gardiner Method improve thinking and daily function in people with Parkinson’s
In this 10-week program, adults with Parkinson’s disease will try the Ronnie Gardiner Method to see if it helps thinking, talking, movement, balance, and quality of life.
-
Beef-Protein Ready-to-Eat Meals to Support Firefighter Recovery
This study tests whether beef-based ready-to-eat meals help firefighters recover better after simulated firefighting tasks, compared with plant-based meals.
-
How pork protein affects recovery after simulated firefighting
This study tests whether pork-based meals help firefighters recover better and perform sooner after hard simulated fire drills, compared with plant-based meals or carbohydrate-focused meals.
-
LpD3.5 Intervention for Gut Health and Cognition in Older Adults with MCI
In older adults with mild cognitive impairment, this study tests whether daily LpD3.5 capsules can improve gut health and potentially cognition compared with placebo.
-
Ketone and Carbohydrate Supplementation in Endurance Cycling
This study tests whether adding ketones to a carb plan helps amateur endurance cyclists perform better and think more clearly during long, exhausting rides.
-
Appetite and Thinking Response to a Breakfast Cereal
This study tests how eating a ready-to-eat breakfast cereal affects appetite and thinking in healthy adults who regularly eat cereal.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.